Eagle Pharmaceuticals
EGRX
$4.45
Share price
1.14%
Change (1 day)
-84.21%
Change (1 year)
Categories
Operating Margin for Eagle Pharmaceuticals (EGRX)
Operating Margin as of May 2024 (TTM): 21.96%
According to Eagle Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is 21.96%. At the end of 2021 the company had an Operating Margin of -2.65%.
Operating Margin history for Eagle Pharmaceuticals from 2013 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -2.65% | -121.96% |
| 2020 | 12.07% | 7.53% |
| 2019 | 11.23% | -29.63% |
| 2018 | 15.96% | -48.22% |
| 2017 | 30.82% | 9.29% |
| 2016 | 28.20% | 625.47% |
| 2015 | 3.89% | -103.85% |
| 2014 | -100.91% | 98.68% |
| 2013 | -50.79% | -93.6% |
| 2012 | -794.17% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | 4.19% | 🇺🇸 USA |
 Novartis NVS | 17.27% | -21.36% | 🇨🇭 Switzerland |
 Eli Lilly LLY | 24.66% | 12.30% | 🇺🇸 USA |
 Amgen AMGN | 34.59% | 57.51% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | -12.39% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 22.54% | 2.64% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -20.53% | -193.49% | 🇮🇱 Israel |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.